Free Trial

US Bancorp DE Lowers Holdings in Astera Labs, Inc. $ALAB

Astera Labs logo with Computer and Technology background

Key Points

  • US Bancorp DE has reduced its holdings in Astera Labs, Inc. by 51.3% in the first quarter, now owning 3,091 shares valued at approximately $184,000.
  • A number of hedge funds significantly increased their stakes in Astera Labs during the fourth quarter, with Driehaus Capital Management raising its holdings by 16,640.4%.
  • Astera Labs reported quarterly earnings of $0.44 per share, exceeding analysts' estimates and showing a revenue increase of 149.5% year-over-year.
  • Need better tools to track Astera Labs? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

US Bancorp DE lessened its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 51.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,091 shares of the company's stock after selling 3,259 shares during the period. US Bancorp DE's holdings in Astera Labs were worth $184,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Lord Abbett & CO. LLC grew its position in shares of Astera Labs by 318.9% in the fourth quarter. Lord Abbett & CO. LLC now owns 1,818,600 shares of the company's stock valued at $240,873,000 after purchasing an additional 1,384,498 shares during the last quarter. Driehaus Capital Management LLC boosted its position in shares of Astera Labs by 16,640.4% in the fourth quarter. Driehaus Capital Management LLC now owns 1,324,330 shares of the company's stock valued at $175,408,000 after acquiring an additional 1,316,419 shares during the period. Polar Capital Holdings Plc acquired a new stake in shares of Astera Labs in the fourth quarter worth $126,812,000. BNP Paribas Financial Markets increased its position in Astera Labs by 4,172.8% during the fourth quarter. BNP Paribas Financial Markets now owns 816,619 shares of the company's stock worth $108,161,000 after acquiring an additional 797,507 shares during the period. Finally, Voya Investment Management LLC raised its stake in Astera Labs by 153.0% during the 4th quarter. Voya Investment Management LLC now owns 637,737 shares of the company's stock valued at $84,468,000 after purchasing an additional 385,693 shares during the last quarter. Institutional investors own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on ALAB shares. Wall Street Zen upgraded Astera Labs from a "hold" rating to a "buy" rating in a research report on Saturday. Barclays reissued an "overweight" rating and issued a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a report on Thursday, August 7th. Susquehanna lifted their target price on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research report on Thursday, August 7th. Evercore ISI increased their price target on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. Finally, Zacks Research raised Astera Labs to a "strong-buy" rating in a report on Tuesday, August 12th. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $129.13.

Check Out Our Latest Stock Analysis on Astera Labs

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 152,517 shares of the stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total value of $25,978,220.61. Following the sale, the chief executive officer directly owned 450,001 shares in the company, valued at $76,648,670.33. This represents a 25.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Manuel Alba sold 13,259 shares of the business's stock in a transaction that occurred on Monday, July 21st. The stock was sold at an average price of $111.00, for a total transaction of $1,471,749.00. Following the completion of the transaction, the director directly owned 1,874,498 shares of the company's stock, valued at approximately $208,069,278. This represents a 0.70% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 2,176,436 shares of company stock worth $259,714,061 in the last three months. 12.50% of the stock is owned by corporate insiders.

Astera Labs Stock Performance

NASDAQ:ALAB traded down $0.24 during mid-day trading on Monday, reaching $185.61. 3,279,258 shares of the company's stock were exchanged, compared to its average volume of 4,964,368. The business's fifty day simple moving average is $115.49 and its two-hundred day simple moving average is $90.13. Astera Labs, Inc. has a one year low of $36.85 and a one year high of $199.47. The firm has a market capitalization of $30.85 billion, a PE ratio of 332.10, a price-to-earnings-growth ratio of 4.71 and a beta of 1.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%. The business had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. During the same period in the prior year, the business posted $0.13 earnings per share. Astera Labs's quarterly revenue was up 149.5% on a year-over-year basis. As a group, equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Further Reading

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines